Urologic Cancer
42
11
14
11
Key Insights
Highlights
Success Rate
79% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
7.1%
3 terminated out of 42 trials
78.6%
-7.9% vs benchmark
12%
5 trials in Phase 3/4
18%
2 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (42)
Extracellular Vesicles and Chemotherapy-Induced Peripheral Neuropathy
Fluid Challenge and Plasma Volume, During Surgery
An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG
A Study of Adjuvant NDV-01 (Sustained-release Gemcitabine-docetaxel) for the Treatment of Intermediate Risk NMIBC Following TURBT
A Study of NDV-01 as an Intravesical Administration to Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC), Refractory to First-line Therapy
A Study of NDV-01 (Sustained-release Gemcitabine-docetaxel) in Participants With Non-muscle Invasive Bladder Cancer
Preoperative Smoking Cessation in Patients Undergoing Surgery
Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients
A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
Comparison of the Integrated Posterior-Anterior-Lateral Approach and the Posterior Approach in Robotic Radical Prostatectomy
Interest of Magnetic Resonance Imaging in the Diagnosis of Upper Urinary Tract Invasive Tumours
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
Vaginal Dilator Therapy After Pelvic Radiation
VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy
Palliative Radiotherapy in Symptomatic Pelvic Soft Tissue Tumors
The Registry of Genetic Expression of Taiwan Urologic Cancer
In-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients
Exploring the Association of Imaging and Tumor Microenvironment in Urologic Cancer Using Radiogenomic Approach（Radiogenomics-Urinary）
Optimized Perioperative Antibiotic Prophylaxis in Radical Cystectomy
PROM Project Urology